Rubattu et al disease. Nature Genetics 1996; 13: 429-32. 8. Rubattu S, Lee MA, De Paolis P, et al. Altered structure, regulation and function of the gene encoding atrial natri- uretic peptide in the stroke-prone spontaneously hyper- tensive rat. Circ Res 1999; 85: 900-5. 9. Rubattu S, Giliberti R, De Paolis P, Spinsanti P, Venturelli V, Volpe M. Effect of a regulatory mutation on the rat atri- al natriuretic peptide gene transcription. Peptides 2002; 23: 555-60. 10. De Paolis P, Nobili V, Lombardi A, et al. Role of a molecu- lar variant of the rat atrial natriuretic peptide gene on vas- cular remodeling. Submitted 2006. 11. Rubattu S, Ridker PM, Meir S, Hennekens CH, Volpe M, Lindpaintner K. The gene encoding atrial natriuretic pep- tide and the risk of human stroke. Circulation 1999; 100: 1722-6. 12. Rubattu S, Stanzione R, Di Angelantonio E, et al. Atrial natriuretic peptide gene polymorphisms and risk of is- chemic stroke in humans. Stroke 2004; 35: 814-8. 13. Itoh H, Pratt RE, Dzau VJ. Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J Clin Invest 1990; 86:1690-7. 14. Morishita R, Gibbons GH, Pratt RE, et al. Autocrine and paracrine effects of atrial natriuretic peptide gene trans- fer on vascular smooth muscle and endothelial cellular growth. J Clin Invest 1994; 94: 824-9. 15. Horio T, Nishikimi T, Yoshihara F, et al. Inhibitory regula- tion of hypertrophy by endogenous atrial natriuretic pep- tide in cultured cardiac myocytes. Hypertension 2000; 35:19-24. 16. Wang TJ, Larson MO, Levy D, Benjamin EJ, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. NEJM 2004; 350: 655-63. 17. Makikallio AM, Makikallio TH, Korpelainen JT, et al. Natri- uretic peptides and mortality after stroke. Stroke 2005; 36: 1016-20. 18. John SW, Krege JH, Oliver PM, et al. Genetic decreases in atrial natriuretic peptide and salt sensitive hyperten- sion. Science 1995; 267: 679-81. 19. Steinhelper ME, Cochrane KL, Field LJ. Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes. Hypertension 1990; 16: 301-7. 20. Oliver PM, Fox JE, Kim R, et al. Hypertension, cardiac hy- pertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci USA 1997; 94: 14730-5. 21. Rutledge DR, Sun Y, Ross EA. Polymorphisms within the atrial natriuretic peptide gene in essential hypertension. J Hypertens 1995; 13: 953-5. 22. Nakayama T, Soma M, Takahashi Y, et al. Nucleotide se- quence of the 5’-flanking region of the type A human na- triuretic peptide receptor gene and association analysis using a novel microsatellite in essential hypertension. Am J Hypertens 1999; 12: 1144-8. 23. Chien KR, Knowlton KU, Zhu H, et al. Regulation of car- diac gene expression during myocardial growth and hy- pertrophy: Molecule studies of an adaptive physiologic respone. FASEB J1991; 5: 3037-46. 24. Rubattu S, Bigatti G, Evangelista A, Lanzani C, et al. As- sociation of atrial natriuretic peptide and tyep-A natriuret- ic peptide receptor gene polymorphisms with left ventric- ular mass in human essential hypertension. JACC, 2006 (In press). 25. Molkentin JD. A friend within the heart: Natriuretic peptide receptor signaling. J Clin Invest 2003; 111: 1275-7. 81